97 related articles for article (PubMed ID: 3676728)
1. Down-regulation of tryptamine receptors following chronic administration of clorgyline.
Martin LL; Neale RF; Wood PL
Brain Res; 1987 Sep; 419(1-2):239-43. PubMed ID: 3676728
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
3. [3H]tryptamine binding sites of rat cerebral cortex: pharmacological profile and plasticity.
Graham D; Langer SZ
Neuropharmacology; 1987 Aug; 26(8):1093-7. PubMed ID: 3116448
[TBL] [Abstract][Full Text] [Related]
4. Effects of age and of chronic antidepressant treatment on [3H]tryptamine and [3H]dihydroalprenolol binding to rat cortical membranes.
Mousseau DD; McManus DJ; Baker GB; Juorio AV; Dewhurst WG; Greenshaw AJ
Cell Mol Neurobiol; 1993 Feb; 13(1):3-13. PubMed ID: 8384528
[TBL] [Abstract][Full Text] [Related]
5. 5HT2 receptor changes in rat cortex and platelets following chronic ritanserin and clorgyline administration.
Twist EC; Mitchell S; Brazell C; Stahl SM; Campbell IC
Biochem Pharmacol; 1990 Jan; 39(1):161-6. PubMed ID: 1688704
[TBL] [Abstract][Full Text] [Related]
6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortex.
Twist EC; Mitchell SN; Corn TH; Campbell IC
Eur J Pharmacol; 1991 Apr; 196(2):157-60. PubMed ID: 1908389
[TBL] [Abstract][Full Text] [Related]
8. The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysis.
Twist EC; Brammer MJ; Stephenson JD; Corn TH; Campbell IC
Biochem Pharmacol; 1990 Nov; 40(9):2111-6. PubMed ID: 2122900
[TBL] [Abstract][Full Text] [Related]
9. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
10. [3H]tryptamine binding sites are not identical to monoamine oxidase in rat brain.
Perry DC; Grimm LJ; Kettler KG; Kellar KJ
J Neurochem; 1988 Nov; 51(5):1535-40. PubMed ID: 3139835
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic treatment with selective monoamine oxidase inhibitors and specific 5-hydroxytryptamine uptake inhibitors on [3H]paroxetine binding to cerebral cortical membranes of the rat.
Graham D; Tahraoui L; Langer SZ
Neuropharmacology; 1987 Aug; 26(8):1087-92. PubMed ID: 2958720
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and receptor studies in rat brain: effects of clorgyline.
Campbell IC; Gallager DW; Hamburg MA; Tallman JF; Murphy DL
Eur J Pharmacol; 1985 May; 111(3):355-64. PubMed ID: 2990957
[TBL] [Abstract][Full Text] [Related]
13. Circadian studies of 5HT2 receptors: effects of clorgyline administration.
Koshikawa N; Durcan MJ; Dunn G; Campbell IC
Pharmacol Biochem Behav; 1988 Jun; 30(2):347-50. PubMed ID: 3174765
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
Savage DD; Mendels J; Frazer A
J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
[TBL] [Abstract][Full Text] [Related]
15. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
Benmansour S; Brunswick DJ
Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of 3H-imipramine binding sites in rat cerebral cortex after prenatal exposure to antidepressants.
Montero D; de Ceballos ML; Del Rio J
Life Sci; 1990; 46(22):1619-26. PubMed ID: 2161976
[TBL] [Abstract][Full Text] [Related]
17. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Itzhak Y; Mash D; Zhang SH; Stein I
Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
[TBL] [Abstract][Full Text] [Related]
18. Role of serotonergic input in the down-regulation of beta-adrenoceptors following long-term clorgyline treatment.
Aulakh CS; Cohen RM; Dauphin MM; McLellan CA; Murphy DL
Eur J Pharmacol; 1988 Oct; 156(1):63-70. PubMed ID: 2463178
[TBL] [Abstract][Full Text] [Related]
19. Structural relationships in the inhibition of [3H]tryptamine binding to rat brain membranes in vitro by phenylalkylamines.
Martin LL; Roland DM; Neale RF; Wood PL
Eur J Pharmacol; 1986 Dec; 132(1):53-5. PubMed ID: 3816964
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of tryptamine binding sites following chronic molindone administration. A comparison with responses of dopamine and 5-hydroxytryptamine receptors.
Nguyen TV; Juorio AV
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):366-71. PubMed ID: 2586632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
